A. OBJECTIVE The primary goal of the UNC DDRC is to advance productive, innovative, collaborative research on the pathogenesis and treatment/prevention of mental retardation and neurodevelopmental disorders by providing DDRC Investigators with administrative and core research support in the context of a stimulating, interactive environment. The BMC advances this goal through three interdependent objectives, each of which reflects our expertise in behavioral measurement in humans and in mice, and our successful linkage of these two domains: 1. Traditional approaches to research in mental retardation and developmental disability have used standard, general phenotype measures like IQ, adaptive behavior, or global impressions. However, it has become increasingly apparent that the phenotypes associated with developmental disorders are complex and that a more detailed elucidation of these phenotypes facilitates the search for neural correlations, genetic mechanisms, and efficacious interventions. For example, global assessments of developmental status can be replaced with specific """"""""red flags"""""""" that are associated with abnormal brain development or gene function, and global clinical constructs (e.g., autism) can be refined into quantitative dimensional symptom measures that may be more directly linked to neurological and genetic variation. One overarching objective of the BMC is to develop innovative phenotyping procedures that can be used in humans and mice to tap behaviors associated with clinical syndromes. 2. The innovative phenotyping procedures developed in Objective 1 are of particular value when they are deployed in neurobiological and genetic studies. Our second objective is to facilitate the use of comprehensive phenotyping in neurobiological and genetic studies of clinical syndromes. Effective integration of behavior with neurobiology and genetics is facilitated through consulting with DDRC researchers regarding measurement and design, providing laboratory space and expertise, and further refinement of phenotyping procedures. The Mouse BPL provides researchers with a multifaceted behavioral phenotyping battery (described in detail below) that goes well beyond the level of assessment that could be sustained by an independent researcher, and the Human BPL provides laboratory space, equipment, and expertise for state-of-the-art behavioral phenotyping. 3. Finally, research on interventions evokes additional challenges such as the need to identify disorder-specific features that underlie functional impairment, to evoke behaviors in mice that could be related to clinical symptoms, and to ascertain relevant human populations in which interventions can be tested. A third objective of the BMC is to integrate innovative and comprehensive phenotypic methods in the context of clinical intervention studies.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Center Core Grants (P30)
Project #
5P30HD003110-44
Application #
8314045
Study Section
Special Emphasis Panel (ZHD1)
Project Start
Project End
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
44
Fiscal Year
2011
Total Cost
$529,952
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Lyu, Ilwoo; Kim, Sun Hyung; Girault, Jessica B et al. (2018) A cortical shape-adaptive approach to local gyrification index. Med Image Anal 48:244-258
Klusek, Jessica; Ruber, Alexis; Roberts, Jane E (2018) Impaired eye contact in the FMR1 premutation is not associated with social anxiety or the broad autism phenotype. Clin Neuropsychol 32:1337-1352
Harrop, Clare; Jones, Desiree; Zheng, Shuting et al. (2018) Circumscribed Interests and Attention in Autism: The Role of Biological Sex. J Autism Dev Disord 48:3449-3459
Tu, Liyun; Styner, Martin; Vicory, Jared et al. (2018) Skeletal Shape Correspondence Through Entropy. IEEE Trans Med Imaging 37:1-11
Laxman, D J; Greenberg, J S; DaWalt, L S et al. (2018) Medication use by adolescents and adults with fragile X syndrome. J Intellect Disabil Res 62:94-105
Lyu, Ilwoo; Perdomo, Jonathan; Yapuncich, Gabriel S et al. (2018) Group-wise Shape Correspondence of Variable and Complex Objects. Proc SPIE Int Soc Opt Eng 10574:
Nowell, Sallie W; Watson, Linda R; Faldowski, Richard A et al. (2018) An Initial Psychometric Evaluation of the Joint Attention Protocol. J Autism Dev Disord 48:1932-1944
Jha, Shaili C; Xia, Kai; Schmitt, James Eric et al. (2018) Genetic influences on neonatal cortical thickness and surface area. Hum Brain Mapp 39:4998-5013
Barstein, Jamie; Martin, Gary E; Lee, Michelle et al. (2018) A Duck Wearing Boots?! Pragmatic Language Strategies for Repairing Communication Breakdowns Across Genetically Based Neurodevelopmental Disabilities. J Speech Lang Hear Res 61:1440-1454
Woodbury-Smith, Marc; Paterson, Andrew D; O'Connor, Irene et al. (2018) A genome-wide linkage study of autism spectrum disorder and the broad autism phenotype in extended pedigrees. J Neurodev Disord 10:20

Showing the most recent 10 out of 376 publications